Ajanta Pharma Ltd. · 66-41 · INDIA
For Ajanta Pharma Ltd. · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product is Kamarga | Kamarga; product code is 65 P - - 02 Sildenafil Citrate (Regulator) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 01/20/2017; address is B-4/5/6 Midc Industrial Area , District - Aurangabad , Paithan, Maharashtra INDIA, verified against its source on 2026-09-16.
- Firm
- Ajanta Pharma Ltd. verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- INDIA verified
- Address
- B-4/5/6 Midc Industrial Area , District - Aurangabad , Paithan, Maharashtra INDIA verified
- Date published
- 01/20/2017 verified
- Product code
- 65 P - - 02 Sildenafil Citrate (Regulator) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Kamarga | Kamarga each item verified
- FDA notes
- Product contains Sildenafil Citrate | Product contains Sildenafil Citrate each item verified
What the source says
Ajanta Pharma Ltd. Date Published : 01/20/2017 B-4/5/6 Midc Industrial Area , District - Aurangabad , Paithan, Maharashtra INDIA 65 P - - 02 Sildenafil Citrate (Regulator) Date Published: 01/20/2017 Desc: Kamarga Notes: Product contains Sildenafil Citrate 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 01/20/2017 Desc: Kamarga Notes: Product contains Sildenafil Citrate
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.